Cawachi Limited reports slight sales increase, lower profits for FY2025

Cawachi Limited (TSE:2664) announced consolidated financial results for the fiscal year ended March 15, 2025, reporting net sales of JPY 287,816 million, a 0.6% increase year-over-year. However, operating profit decreased by 1.8% to JPY 7,461 million, and ordinary profit declined by 3.1% to JPY 8,340 million. Profit attributable to owners of the parent company increased by 3.6% to JPY 4,884 million. The company attributes the challenging environment to rising commodity prices, exchange rate fluctuations, and intense competition within the drugstore industry. Cawachi opened eight new stores and six dispensing pharmacies while closing three stores and one dispensing pharmacy, bringing its total store count to 380. For the fiscal year ending March 15, 2026, Cawachi forecasts net sales of JPY 292,000 million, operating profit of JPY 7,800 million, and profit attributable to owners of parent of JPY 4,900 million. The company plans to continue focusing on opening new stores with dispensing pharmacies and enhancing preventive healthcare offerings. A dividend of JPY 80 per share is planned.